Treace Medical Concepts, Inc. (TMCI) Misses Q1 EPS by 3c, Beats on Revenue; Lowers FY24 Revenue Guidance
Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q1 EPS of ($0.30), $0.03 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $51.1 million versus the consensus estimate of $49.07 million.
GUIDANCE:
Treace Medical Concepts, Inc. lowers guidance range for full-year 2024, expecting revenues of $201 million to $211 million from $220 million to $225 million.
For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.